Pfizer

Associate Director, Biostatistics

Posted on: 22 Oct 2021

Cambridge, MA

Job Description

ROLE SUMMARY

Pfizer's Early Clinical Development Statistics group is looking for a statistician with an interest in preclinical statistics and collaborating with research scientists in drug discovery and development. The candidate will work closely with laboratory scientists seeking to discover new medicines in a variety of therapeutic areas by supporting the design and analysis of preclinical experiments, covering all aspects of drug discovery from disease target identification, pharmacology studies, animal model development, biomarker development and demonstration of proof-of-concept. The ideal candidate will have a genuine interest in understanding drug target biology to provide effective statistical consultation with biological scientists.

ROLE RESPONSIBILITIES

Collaborate with preclinical laboratory scientists across research units (Immunology & Inflammation, Internal Medicine, Rare Disease, CTI) to design and analyze experiments.

Summarize statistical analyses in reports and presentations.

Bring innovative statistical thinking and methods to help drive the enhanced quantitative drug discovery and development paradigm within Pfizer.

Ensure rigorous approaches are taken to ensure good scientific practices are followed: excellent statistical methods utilized and documented in protocols, analysis plans and manuscripts, and assay methods are appropriately blinded, randomized and designed.

Serve as a core member of scientific teams responsible for determining strategy and delivering results in a timely and high-quality manner.

Understand the target biology and improve existing biomarkers, endpoints, derive new endpoints, and develop fit-for-purpose statistical models.

Where possible, standardize processes and methodologies within and across therapeutic areas.

Provide statistical expertise on regulatory submissions and ensure quality of deliverables.

BASIC QUALIFICATIONS

PhD in Statistics/Biostatistics and at least 3-5 years of pharmaceutical experience or a Master degree in Statistics/Biostatistics and at least 5-8 years of pharmaceutical experience.

Interest in biology is essential including bachelor’s or graduate-level training.

Previous preclinical/non-clinical statistics experience.

Must have strong technical competence in statistical techniques.

Capability to provide statistical leadership to cross-functional teams.

Ideal candidate will understand design of experiments, assay development, and statistical applications for preclinical research.

Strong computational skills in R or SAS.

Strong written and verbal communication skills.

The ability to work collaboratively with research scientists.

Demonstrated ability to work effectively as a part of a team.

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

OTHER JOB DETAILS

Eligible for Employee Referral Bonus

Eligible for Relocation Package

Pfizer

New York, New York

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names.

Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.